Monitor: molecules and profiles

Same author

Designed multiple ligands: basic research vs clinical outcomes.

Current medicinal chemistry·2012

Same author

Semicarbazide-sensitive amine oxidase/vascular adhesion protein 1: recent developments concerning substrates and inhibitors of a promising therapeutic target.

Current medicinal chemistry·2008

Same author

Thymidylate synthase structure, function and implication in drug discovery.

Current medicinal chemistry·2005

Same author

Semicarbazide-sensitive amine oxidase: current status and perspectives.

Current medicinal chemistry·2004

Same author

Selective ACAT inhibitors as promising antihyperlipidemic, antiathero-sclerotic and anti-Alzheimer drugs.

Mini reviews in medicinal chemistry·2003

Same author

Characterization and pharmacological actions of tecostanine, an alkaloid of Tecoma stans.

Die Pharmazie·2003

Same journal

Targeting the GLP-1 receptor pathways for dual management of obesity and depression.

Drug discovery today·2026

Same journal

Chemical intervention strategies targeting MYC for cancer therapy.

Drug discovery today·2026

Same journal

How many protein pairs can we chemically target?

Drug discovery today·2026

Same journal

From trial-and-error to inverse design: how AI is redefining drug delivery systems.

Drug discovery today·2026

Same journal

Critical evaluation of the key mediators causing life-threatening symptoms during human anaphylaxis.

Drug discovery today·2026

Same journal

A20 as a novel immunoregulatory target for neuroinflammation.

Drug discovery today·2026

Related Experiment Videos

Monitor: molecules and profiles

Related Concept Videos

Designed multiple ligands: basic research vs clinical outcomes.

Semicarbazide-sensitive amine oxidase/vascular adhesion protein 1: recent developments concerning substrates and inhibitors of a promising therapeutic target.

Thymidylate synthase structure, function and implication in drug discovery.

Semicarbazide-sensitive amine oxidase: current status and perspectives.

Selective ACAT inhibitors as promising antihyperlipidemic, antiathero-sclerotic and anti-Alzheimer drugs.

Characterization and pharmacological actions of tecostanine, an alkaloid of Tecoma stans.

Targeting the GLP-1 receptor pathways for dual management of obesity and depression.

Chemical intervention strategies targeting MYC for cancer therapy.

How many protein pairs can we chemically target?

From trial-and-error to inverse design: how AI is redefining drug delivery systems.

Critical evaluation of the key mediators causing life-threatening symptoms during human anaphylaxis.

A20 as a novel immunoregulatory target for neuroinflammation.

Related Experiment Videos

Monitor: molecules and profiles

Related Concept Videos

Related Articles

Designed multiple ligands: basic research vs clinical outcomes.

Semicarbazide-sensitive amine oxidase/vascular adhesion protein 1: recent developments concerning substrates and inhibitors of a promising therapeutic target.

Thymidylate synthase structure, function and implication in drug discovery.

Semicarbazide-sensitive amine oxidase: current status and perspectives.

Selective ACAT inhibitors as promising antihyperlipidemic, antiathero-sclerotic and anti-Alzheimer drugs.

Characterization and pharmacological actions of tecostanine, an alkaloid of Tecoma stans.

Targeting the GLP-1 receptor pathways for dual management of obesity and depression.

Chemical intervention strategies targeting MYC for cancer therapy.

How many protein pairs can we chemically target?

From trial-and-error to inverse design: how AI is redefining drug delivery systems.

Critical evaluation of the key mediators causing life-threatening symptoms during human anaphylaxis.

A20 as a novel immunoregulatory target for neuroinflammation.